CLEC-2, the novel platelet activation receptor and its internal ligand, podoplanin.
Suzuki-Inoue
Katsue
K
D000818:Animals; D055808:Drug Discovery; D006801:Humans; D037181:Lectins, C-Type / Q000502:physiology; D008024:Ligands; D008562:Membrane Glycoproteins / Q000502:physiology; D009362:Neoplasm Metastasis / Q000235:genetics; D009360:Neoplastic Cells, Circulating; D015539:Platelet Activation / Q000235:genetics; D010975:Platelet Aggregation Inhibitors; D010980:Platelet Membrane Glycoproteins; D043562:Receptors, G-Protein-Coupled; D014757:Viper Venoms; D000098853:Podoplanin
D037181:Lectins, C-Type; D008024:Ligands; D008562:Membrane Glycoproteins; D010975:Platelet Aggregation Inhibitors; D010980:Platelet Membrane Glycoproteins; D043562:Receptors, G-Protein-Coupled; D014757:Viper Venoms; C104778:CLEC2B protein, human; C117468:PDPN protein, human; D000098853:Podoplanin; C039351:platelet activating factor receptor; C112292:rhodocytin protein, Calloselasma rhodostoma